TrialOncology2009

Clinical predictors of severe cetuximab-induced rash: observations from 933 patients enrolled in north central cancer treatment group study N0147.

Aminah Jatoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.